Table 3 Imaging and medications of patients regarding access to care, by race
|
Black (N = 68) |
White (N = 41) | Hispanic (N = 33) |
Other (N = 7) | P-value | |
|---|---|---|---|---|---|
| Number of patients with additional cardiac imaging | |||||
| MUGA scan | 8 | 3 | 5 | 0 | p = 0.55 |
| Cardiac CT/MRI | 2 | 3 | 1 | 0 | p = 0.63 |
| Stress test | 13 | 9 | 8 | 1 | p = 0.89 |
| RHC | 3 | 3 | 0 | 0 | p = 0.42 |
| LHC | 4 | 3 | 1 | 0 | p = 0.78 |
| Medication post-chemo | |||||
| Beta blocker | 38 | 20 | 14 | 7 | p = 0.12 |
| ACEI/ARB | 43 | 18 | 12 | 3 | p = 0.047 |
| Diuretic | 20 | 13 | 6 | 1 | p = 0.54 |
| CCB | 20 | 6 | 4 | 2 | p = 0.13 |
| Hydralazine | 5 | 2 | 0 | 0 | p = 0.38 |
| Nitrate | 2 | 3 | 0 | 0 | p = 0.33 |
| MRA | 2 | 4 | 1 | 1 | p = 0.28 |
| Antiarrhythmic | 2 | 2 | 0 | 0 | p = 0.60 |
| Aspirin | 19 | 15 | 7 | 3 | p = 0.43 |
| Statin | 24 | 16 | 11 | 3 | p = 0.94 |